HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system.

Abstract
Low-dose dexamethasone has been widely used for the prevention of nausea and vomiting after chemotherapy and surgical procedures and to treat motion sickness due to its minimal adverse effects, but the mechanisms underlying its anti-motion sickness effects are poorly understood. Previous studies have demonstrated that the endocannabinoid system is suppressed by motion sickness but stimulated by dexamethasone. The aim of the present study was to determine whether dexamethasone has an anti-motion sickness effect in rats and to elucidate the mechanism of this action. We used HPLC-MS/MS to measure the plasma concentrations of anandamide and 2-arachidonoylglycerol+1-arachidonoylglycerol, and we employed real-time quantitative PCR (qRT-PCR) and/or Western blot analysis to assay the expression of N-acylphosphatidyl-ethanolamine hydrolyzing phospholipase D, sn-1-selective diacylglycerol lipase, fatty acid hydrolase, monoacylglycerol lipase and endocannabinoid CB1 receptor in the dorsal vagal complex and stomach of rats exposed to a motion sickness protocol. The results showed that dexamethasone lowered the motion sickness index and restored the levels of endogenous cannabinoids and the expression of the endocannabinoid CB1 receptor, which declined after the induction of motion sickness, in the dorsal vagal complex and stomach.
AuthorsYan Zheng, Xiao-Li Wang, Feng-Feng Mo, Min Li
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 727 Pg. 99-105 (Mar 15 2014) ISSN: 1879-0712 [Electronic] Netherlands
PMID24508383 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • 1-arachidonylglycerol
  • Antiemetics
  • Arachidonic Acids
  • Cnr1 protein, rat
  • Endocannabinoids
  • Glycerides
  • Polyunsaturated Alkamides
  • RNA, Messenger
  • Receptor, Cannabinoid, CB1
  • Dexamethasone
  • glyceryl 2-arachidonate
  • anandamide
Topics
  • Animals
  • Antiemetics (pharmacology)
  • Arachidonic Acids (blood)
  • Dexamethasone (pharmacology)
  • Disease Models, Animal
  • Endocannabinoids (blood)
  • Glycerides (blood)
  • Male
  • Motion Sickness (blood, physiopathology, prevention & control)
  • Polyunsaturated Alkamides (blood)
  • RNA, Messenger (metabolism)
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB1 (genetics, metabolism)
  • Severity of Illness Index
  • Signal Transduction (drug effects)
  • Stomach (innervation)
  • Vagus Nerve (drug effects, metabolism, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: